SCHEDULE: MJL Manager LLC Discloses 5.7% Stake in Soligenix
Schedule 13G
MJL Manager LLC and Michael Liu have filed a Schedule 13G disclosing a combined beneficial ownership of 5.7% in Soligenix, Inc. common stock.
Summary
- MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP have collectively reported beneficial ownership of 983,588 shares of Soligenix, Inc. common stock.
- This represents a 5.7% stake in the company for Michael Liu and a 5.2% stake for MJL Manager LLC.
- The filing indicates that these shares are held for investment purposes and not to influence the control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral regulatory disclosure indicating institutional interest without specific strategic intent to change company operations.
Positives
- Institutional or professional investor interest in Soligenix, Inc. suggests confidence in the company's long-term prospects.
Negatives
- None identified in this filing.
Risks
- The investment is subject to market volatility and the inherent risks associated with the biotechnology sector.
Future Outlook
The reporting persons state that the securities were not acquired for the purpose of changing or influencing the control of the issuer.
Management Comments
- The reporting persons certify that the information set forth in the statement is true, complete, and correct.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures for investment firms crossing the 5% ownership threshold, often signaling institutional accumulation in small-cap biotech firms.
Comparison to Industry Standards
- The filing follows standard SEC regulatory requirements for beneficial ownership reporting under Rule 13d-1.
- The disclosure format is consistent with typical institutional investor reporting for publicly traded micro-cap and small-cap companies.
Related Party Transactions
- Michael Liu is the sole control person of MJL Manager LLC and manages discretionary accounts including Capuchin Capital Fund LP.
Stakeholder Impact
- Increased institutional visibility for Soligenix, Inc. shareholders.
Next Steps
- The reporting persons may file amendments if there are material changes in their percentage of ownership.
Key Dates
| Date | Description |
|---|---|
| 06/22/2026 | Date of event which requires filing of this statement. |
| 06/25/2026 | Date of signature and filing of the Schedule 13G. |
Keywords
Soligenix, SNGX, Schedule 13G, Beneficial Ownership, MJL Manager LLC, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.